Pacific Sun Financial Corp Has $784,000 Stock Position in VanEck Biotech ETF (NASDAQ:BBH)

Pacific Sun Financial Corp cut its stake in shares of VanEck Biotech ETF (NASDAQ:BBH) by 11.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,993 shares of the company’s stock after selling 674 shares during the period. Pacific Sun Financial Corp owned 0.20% of VanEck Biotech ETF worth $784,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Kovitz Investment Group Partners LLC lifted its position in VanEck Biotech ETF by 4.6% during the third quarter. Kovitz Investment Group Partners LLC now owns 3,186 shares of the company’s stock worth $565,000 after purchasing an additional 141 shares during the period. Flagship Harbor Advisors LLC raised its position in shares of VanEck Biotech ETF by 12.1% in the 4th quarter. Flagship Harbor Advisors LLC now owns 1,984 shares of the company’s stock valued at $311,000 after buying an additional 214 shares in the last quarter. Truvestments Capital LLC bought a new stake in shares of VanEck Biotech ETF during the 3rd quarter worth approximately $44,000. FSA Wealth Management LLC acquired a new stake in shares of VanEck Biotech ETF during the 3rd quarter worth approximately $54,000. Finally, Coastline Trust Co bought a new position in VanEck Biotech ETF in the third quarter valued at approximately $59,000. Institutional investors own 32.05% of the company’s stock.

VanEck Biotech ETF Stock Performance

BBH opened at $163.55 on Thursday. The company’s 50 day moving average is $161.10 and its 200-day moving average is $169.49. VanEck Biotech ETF has a 1-year low of $151.35 and a 1-year high of $183.64.

VanEck Biotech ETF Announces Dividend

The firm also recently disclosed a dividend, which was paid on Tuesday, December 24th. Investors of record on Monday, December 23rd were issued a $1.2517 dividend. The ex-dividend date was Monday, December 23rd.

VanEck Biotech ETF Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.